Results 41 to 50 of about 189,830 (273)

Advanced Dental Composite Technology via Bisilanized Dual‐Action Nanofillers for Biofilm Control

Advanced Science, EarlyView.
A multimodal research strategy has led to the development of an innovative resin‐based composite (RBC) with dual antibacterial action. The S_CM‐RBC formula showed strong antibiofilm activity, excellent mechanical strength, and biosafety. It effectively controlled oral bacteria in prevention of caries recurrence, and maintained pulp health in a rat ...
Chenmin Yao, Line Etiennot, Naiera Zayed, Shengjie Liang, Mehraveh Saghi, Jelle Verdonck, Lingyue Liu, Fei Zhang, Wim Teughels, Cui Huang, Kirsten Van Landuyt, Bart Van Meerbeek   +11 more
wiley   +1 more source

A prospective one-year microbiologic survey of combined pneumonia and respiratory failure [PDF]

, 2017
Background: Pneumonia and respiratory failure are common problems in the intensive care unit (ICU) setting, often occurring together. The relative prevalence of pneumonia types (community acquired, hospital acquired, ventilator associated) and causative ...
Fisher, Kristen, Juang, Paul, Kollef, Marin H, Micek, Scott T, Trupka, Tracy   +4 more
core   +2 more sources

Integrating One Health to Mitigate the Emergence and Spread of Antimicrobial Resistance in Livestock and Aquaculture

Animal Research and One Health, EarlyView.
Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali, Delower Hossain, Ridwan Olamilekan Adesola, Anum Hanif, Shamsaldeen Ibrahim Saeed, Muhammad Abdul Mannan, Anoar Jamai Masroure, Kazi Estieque Alam, Md Kamal Hossain, Sabiha Zarin Tasnim Bristi, Md Jisan Ahmed   +10 more
wiley   +1 more source

Advances in community-acquired pneumonia

Therapeutic Advances in Infectious Disease, 2020
Community-acquired pneumonia is one of the commonest and deadliest of the infectious diseases, yet our understanding of it remains relatively poor. The recently published American Thoracic Society and Infectious Diseases Society of America Community ...
Barbara Jones, Grant Waterer
doaj   +1 more source

When to "CAP" off treatment for pneumonia [PDF]

, 2017
Is 5 days of antibiotic therapy really sufficient for adults hospitalized with community-acquired pneumonia? PRACTICE CHANGER: Prescribe 5 days of antibiotic treatment for inpatients with community-acquired pneumonia because it produces the same clinical
Castelli, Gregory, Jarrett, Jennie B.
core  

Expanded CURB-65: A new score system predicts severity of community-acquired pneumonia with superior efficiency [PDF]

, 2016
Aim of this study was to develop a new simpler and more effective severity score for communityacquired pneumonia (CAP) patients. A total of 1640 consecutive hospitalized CAP patients in Second Affiliated Hospital of Zhejiang University were included ...
Dong, Xiao Jun, Falcone, Marco, Farcomeni, Alessio, Liu, Jin Liang, Lu, Rui Qing, Luo, Shu Ya, Shi, Ling Xian, Venditti, Mario, Wu, Xue Jie, Xu, Feng, Zhao, Ying Li, Zhou, Hui   +11 more
core   +1 more source

3: Community‐acquired pneumonia [PDF]

Medical Journal of Australia, 2002
Community-acquired pneumonia is caused by a range of organisms, most commonly Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae and respiratory viruses. Chest x-ray is required for diagnosis. A risk score based on patient age, coexisting illness, physical signs and results of investigations can aid management decisions.
Paul D R, Johnson, Lou B, Irving, John D, Turnidge   +2 more
openaire   +2 more sources

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Effect of vaccination on morbidity and mortality from community-acquired pneumonia

Acta Biomedica Scientifica
Background. Community-acquired pneumonia remains one of the most common and life-threatening forms of pathology among respiratory diseases.The aim of the study. To identify the features of the epidemiology of communityacquired pneumonia in the conditions
T. A. Bayanova, E. S. Stukova, N. A. Kravchenko   +2 more
doaj   +1 more source

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. [PDF]

, 2018
Background Pneumonia is the most common cause of death in children worldwide, accounting for 15% of all deaths of children under 5 years of age. This review summarises the evidence for the empirical antibiotic treatment of community-acquired pneumonia in
Aga Khan University, Beijing Children’s Hospital, Cempra Inc, European Centre for Disease Prevention and Control, GAVI Alliance, Hamilton Health Sciences Corporation, Children’s Hospital of Eastern Ontario, Kuehn J, Malaria Consortium, Paediatric Formulary Committee, Save the Children, Save the Children, Sharland M, UNICEF, University of Malaya, Menzies School of Health Research, World Health Organization, World Health Organization, World Health Organization   +16 more
core   +2 more sources